Arca Biopharma


Life Sciences
Drug discovery based on pharmacogenomics of heart disease.
CO-INVESTOR
Atlas Venture, Skyline Ventures, InterWest Partners
OUTCOME:
IPO (NASDAQ:ABIO) January, 2009.
No items found.


Drug discovery based on pharmacogenomics of heart disease.